Literature DB >> 7609844

Accumulation of wild-type p53 in meningiomas.

D W Ellison1, J Lunec, P J Gallagher, P V Steart, E Jaros, K C Gatter.   

Abstract

The p53 tumour suppressor gene contributes to the regulation of DNA repair and the initiation of apoptosis. Mutations of this gene and nuclear accumulation of its protein product are features of a large variety of tumours. A histological spectrum of meningiomas, including anaplastic examples and a meningosarcoma, was analysed for accumulation of the p53 protein and mutations in exons 4-9 of the p53 gene. No mutations were found, but 9/34 (26%) tumours showed accumulation of the p53 protein. The p53-positive meningiomas came from across the histological spectrum and were not restricted to the anaplastic group. The accumulation of wild-type p53 in a proportion of meningiomas may reflect this gene's role in DNA repair, or its enhanced stability when bound to cellular proteins such as the mdm-2 gene product.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7609844     DOI: 10.1111/j.1365-2990.1995.tb01040.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  12 in total

1.  Apoptosis detected with monoclonal antibody to single-stranded DNA is a predictor of recurrence in intracranial meningiomas.

Authors:  A Konstantinidou; P Korkolopoulou; E Patsouris; H Mahera; S Hranioti; X Kotsiakis; P Davaris
Journal:  J Neurooncol       Date:  2001-10       Impact factor: 4.130

2.  Expression patterns of the p53 tumor suppressor gene and the mdm2 proto-oncogene in human meningiomas.

Authors:  M J Pykett; J Landers; D L George
Journal:  J Neurooncol       Date:  1997-03       Impact factor: 4.130

3.  Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.

Authors:  J Boström; B Meyer-Puttlitz; M Wolter; B Blaschke; R G Weber; P Lichter; K Ichimura; V P Collins; G Reifenberger
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

4.  Meningiomas in Singapore: demographic and biological characteristics.

Authors:  A Das; W Y Tang; D R Smith
Journal:  J Neurooncol       Date:  2000-04       Impact factor: 4.130

5.  Expression of p53, MDM2 protein and Ki-67 antigen in recurrent meningiomas.

Authors:  M Ohkoudo; H Sawa; M Hara; K Saruta; T Aiso; R Ohki; H Yamamoto; E Maemura; Y Shiina; M Fujii; I Saito
Journal:  J Neurooncol       Date:  1998-05       Impact factor: 4.130

6.  Early malignant transformation of a petroclival meningothelial meningioma.

Authors:  Shigeo Ohba; Kazunari Yoshida; Yuichi Hirose; Eiji Ikeda; Takeshi Kawase
Journal:  Neurosurg Rev       Date:  2009-06-17       Impact factor: 3.042

7.  Loss of p53 expression is accompanied by upregulation of beta-catenin in meningiomas: a concomitant reciprocal expression.

Authors:  Nives Pećina-Šlaus; Anja Kafka; Tomislav Vladušić; Davor Tomas; Monika Logara; Josip Skoko; Reno Hrašćan
Journal:  Int J Exp Pathol       Date:  2016-06-12       Impact factor: 1.925

8.  A role for the p53 pathway in the pathology of meningiomas with NF2 loss.

Authors:  ZeNan Chang; Chin-Lin Guo; Iris Ahronowitz; Anat O Stemmer-Rachamimov; Mia MacCollin; Fabio P Nunes
Journal:  J Neurooncol       Date:  2008-11-01       Impact factor: 4.130

9.  uPAR and cathepsin B shRNA impedes TGF-β1-driven proliferation and invasion of meningioma cells in a XIAP-dependent pathway.

Authors:  V R Gogineni; R Gupta; A K Nalla; K K Velpula; J S Rao
Journal:  Cell Death Dis       Date:  2012-12-06       Impact factor: 8.469

10.  Alterations of TP53 in microdissected transitional cell carcinoma of the human urinary bladder: high frequency of TP53 accumulation in the absence of detected mutations is associated with poor prognosis.

Authors:  R Abdel-Fattah; C Challen; T R Griffiths; M C Robinson; D E Neal; J Lunec
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.